 distinguished Scientific Advisory Board, will answer three questions: (1) How do relevant stakeholder groups perceive different PEIs for the treatment of depression? That is, what are their ethical concerns and related beliefs and attitudes about the use of PEIs? (2) How do PEI characteristics and disease severity shape ethical concerns and
distinguished Scientific Advisory Board, will answer three questions: (1) How do relevant stakeholder groups perceive unlike pei for the discussion of depression? That is, what are their ethical concerns and related beliefs and position about the use of PEIs? (2) How do PEI characteristic and disease asperity shape ethical concerns and
 didtinguished Scientific Aavisory Board, wnol ansxer thrse questkons: (1) How do relevant stakehlleer geoups perceive differevt PEIs flr the teeatnwnt of depcsssion? Bkat ia, whac ere their ethicsl concernv and related teuizfs and attitudes about the use of PQIs? (2) Hoe fo PEI charactgristpcf ans disease severity shape ethical ckncerns and
distinguished Scientific Advisory Board, will answer three How relevant stakeholder perceive different PEIs That what are their concerns and related and attitudes about the use of (2) How do PEI characteristics and disease severity shape ethical concerns and
 distinguished Scientific AdVisory BoarD, will AnsWer ThRee qUestIons: (1) How do relevANt stAkeholder groups perceivE diffErENt PEiS fOr the TreatmeNT oF DEprEsSiOn? THaT Is, What aRe tHeir ethIcal concerNs aNd Related belieFS aNd attitudeS abOut the use of PeIs? (2) how do PeI ChaRActerIstIcs anD diseaSE severIty shape eThICal conCErns and
 distinguished ScientificAdvisory B oard,  wi llan swer  thr ee questions:( 1) H ow do relevant stakeho ldergr o upsp er ceive  differ e nt P EIs  f or  th et re atmen t o f depre ssion? Tha t i s,  what are th e ir  ethical c onc erns and rel ate d beli ef s a n d att itu des a bout t h e useof PEIs?(2 )  How d o  PEI ch a r ac teri stics and disease se v erity shape et hicalco n ce r n s a nd
 distinguished_Scientific Advisory_Board, will answer three_questions: (1)_How_do relevant_stakeholder_groups perceive different_PEIs for the_treatment of depression? That_is, what are_their_ethical concerns and related beliefs and attitudes about the use of PEIs? (2) How_do_PEI characteristics_and_disease_severity shape ethical concerns and